GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Marketable Securities

Apollomics (Apollomics) Marketable Securities : $5.76 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Apollomics's Marketable Securities for the quarter that ended in Dec. 2023 was $5.76 Mil.

Apollomics's annual Marketable Securities declined from Dec. 2021 ($47.74 Mil) to Dec. 2022 ($21.94 Mil) and declined from Dec. 2022 ($21.94 Mil) to Dec. 2023 ($5.76 Mil).

Apollomics Marketable Securities Historical Data

The historical data trend for Apollomics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Marketable Securities Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Marketable Securities
23.74 47.74 21.94 5.76

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Marketable Securities Get a 7-Day Free Trial 47.74 23.78 21.94 27.32 5.76

Apollomics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Apollomics  (NAS:APLMW) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Apollomics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Apollomics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Marketable Securities
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.